Item 9 Labs Corp. To Present at the Benzinga Spring Cannabis Capital Conference

CEO Mike Weinberger To Participate on “Collision Course: Cannabis & the Future of Retail” Panel on April 11 at 1 p.m. ET at the Brand Stage

PHOENIX--(BUSINESS WIRE)-- Item 9 Labs Corp. (the “Company”) (OTCQX: INLB) — a vertically integrated U.S. cannabis franchisor and operator—announced today that its Chief Executive Officer Mike Weinberger will present at the Benzinga Cannabis Capital Conference, taking place at the Fontainebleau Miami Beach Hotel in Miami on Tuesday, April 11, and Wednesday, April 12, 2023.

Weinberger will participate on the panel titled “Collision Course: Cannabis & the Future of Retail” on April 11 at 1:00 p.m. ET at the Brand Stage with moderator and Executive Editor of Green Market Report, Debra Borchardt, along with additional industry leaders. The panel will dive into the intersection of the cannabis industry and retail, covering topics such as opportunities and challenges in various markets, the evolution of cannabis retail in the local community, understanding target consumer audiences and how to create an impactful guest experience.

He will also host meetings throughout the conference and is currently accepting meeting invitations. Schedule a one-on-one with Weinberger by contacting him at investors@item9labscorp.com or through the conference’s portal and mobile app.

To learn more about the Benzinga Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis-conference/.

ABOUT ITEM 9 LABS CORP.

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency and well-being. For additional information, visit item9labscorp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005192/en/

Media Contact:

Item 9 Labs Corp.

Interviews@item9labscorp.com

Investor Contact:

Item 9 Labs Corp.

800-403-1140

Investors@item9labscorp.com

Source: Item 9 Labs Corp.